中华儿科杂志
中華兒科雜誌
중화인과잡지
Chinese Journal of Pediatrics
2014年
11期
840-845
,共6页
曹岚%王娜%潘健%古桂雄%胡绍燕%赵文理%柴忆欢
曹嵐%王娜%潘健%古桂雄%鬍紹燕%趙文理%柴憶歡
조람%왕나%반건%고계웅%호소연%조문리%시억환
白血病%细胞增殖%DNA甲基化
白血病%細胞增殖%DNA甲基化
백혈병%세포증식%DNA갑기화
Leukemia%Cell proliferation%DNA methylation
目的 研究miR-34b在白血病细胞株的表达及其启动子区CpG岛甲基化状态,探讨miR-34b甲基化对白血病细胞增殖的影响.方法 采用实时荧光定量聚合酶链反应(qRT-PCR)检测8种白血病细胞株(U937、HL-60、MV4-11、M2R、K562、Raji、CCRF、DAMI) miR-34b的相对表达量,选择同期20例非血液病患儿骨髓细胞作为对照并与其比较.采用甲基化特异PCR检测miR-34b在8种白血病细胞株miR-34b的甲基化程度,选择同期23例非血液病患儿骨髓细胞作为对照并与其比较.地西他滨(5-aza-2-dC)处理HL60及K562细胞,检测其甲基化状态及miR-34b的相对表达量.采用脂质体转染hsa-miR-34b到K562细胞、通过流式细胞仪检测转染效率、CCK-8法检测各时期hsa-miR-34b转染组细胞增殖情况并与未转染组、阴性对照转染组比较.结果 miR-34b在非血液病患儿骨髓细胞、白血病细胞株组的相对表达量分别为5.22±1.15、0.03±0.03,白血病细胞株组与非血液病患儿骨髓细胞相比,差异有统计学意义(t=4.538,P<0.叭).8种白血病细胞株均出现甲基化现象,其甲基化阳性率为100%;23例非血液病患儿骨髓细胞,无一例出现甲基化现象.5-aza-2-dC处理白血病细胞株HL-60及K562后,其甲基化条带均明显减弱,miR-34b的相对表达量均明显升高,分别为处理前的49.5倍和18.8倍.脂质体转染hsa-miR-34b到K562细胞其转染效率为61%,CCK-8法检测hsa-miR-34b转染组各时期均出现细胞增殖抑制作用,与阴性对照转染组相比,差异有统计学意义(48 h:t=9.303,P<0.01;72 h:t=65.617,P<0.01;96 h:t =36.878,P <0.01;120 h:t=18.748,P<0.01).抑制率分别为12.2%、45.7%、32.5%、22.9%,其中72 h抑制作用最明显.结论 启动子区CpG岛甲基化使miR-34b在白血病细胞株表达降低,导致细胞增殖抑制作用减弱,可能是白血病发生或发展的原因之一.
目的 研究miR-34b在白血病細胞株的錶達及其啟動子區CpG島甲基化狀態,探討miR-34b甲基化對白血病細胞增殖的影響.方法 採用實時熒光定量聚閤酶鏈反應(qRT-PCR)檢測8種白血病細胞株(U937、HL-60、MV4-11、M2R、K562、Raji、CCRF、DAMI) miR-34b的相對錶達量,選擇同期20例非血液病患兒骨髓細胞作為對照併與其比較.採用甲基化特異PCR檢測miR-34b在8種白血病細胞株miR-34b的甲基化程度,選擇同期23例非血液病患兒骨髓細胞作為對照併與其比較.地西他濱(5-aza-2-dC)處理HL60及K562細胞,檢測其甲基化狀態及miR-34b的相對錶達量.採用脂質體轉染hsa-miR-34b到K562細胞、通過流式細胞儀檢測轉染效率、CCK-8法檢測各時期hsa-miR-34b轉染組細胞增殖情況併與未轉染組、陰性對照轉染組比較.結果 miR-34b在非血液病患兒骨髓細胞、白血病細胞株組的相對錶達量分彆為5.22±1.15、0.03±0.03,白血病細胞株組與非血液病患兒骨髓細胞相比,差異有統計學意義(t=4.538,P<0.叭).8種白血病細胞株均齣現甲基化現象,其甲基化暘性率為100%;23例非血液病患兒骨髓細胞,無一例齣現甲基化現象.5-aza-2-dC處理白血病細胞株HL-60及K562後,其甲基化條帶均明顯減弱,miR-34b的相對錶達量均明顯升高,分彆為處理前的49.5倍和18.8倍.脂質體轉染hsa-miR-34b到K562細胞其轉染效率為61%,CCK-8法檢測hsa-miR-34b轉染組各時期均齣現細胞增殖抑製作用,與陰性對照轉染組相比,差異有統計學意義(48 h:t=9.303,P<0.01;72 h:t=65.617,P<0.01;96 h:t =36.878,P <0.01;120 h:t=18.748,P<0.01).抑製率分彆為12.2%、45.7%、32.5%、22.9%,其中72 h抑製作用最明顯.結論 啟動子區CpG島甲基化使miR-34b在白血病細胞株錶達降低,導緻細胞增殖抑製作用減弱,可能是白血病髮生或髮展的原因之一.
목적 연구miR-34b재백혈병세포주적표체급기계동자구CpG도갑기화상태,탐토miR-34b갑기화대백혈병세포증식적영향.방법 채용실시형광정량취합매련반응(qRT-PCR)검측8충백혈병세포주(U937、HL-60、MV4-11、M2R、K562、Raji、CCRF、DAMI) miR-34b적상대표체량,선택동기20례비혈액병환인골수세포작위대조병여기비교.채용갑기화특이PCR검측miR-34b재8충백혈병세포주miR-34b적갑기화정도,선택동기23례비혈액병환인골수세포작위대조병여기비교.지서타빈(5-aza-2-dC)처리HL60급K562세포,검측기갑기화상태급miR-34b적상대표체량.채용지질체전염hsa-miR-34b도K562세포、통과류식세포의검측전염효솔、CCK-8법검측각시기hsa-miR-34b전염조세포증식정황병여미전염조、음성대조전염조비교.결과 miR-34b재비혈액병환인골수세포、백혈병세포주조적상대표체량분별위5.22±1.15、0.03±0.03,백혈병세포주조여비혈액병환인골수세포상비,차이유통계학의의(t=4.538,P<0.팔).8충백혈병세포주균출현갑기화현상,기갑기화양성솔위100%;23례비혈액병환인골수세포,무일례출현갑기화현상.5-aza-2-dC처리백혈병세포주HL-60급K562후,기갑기화조대균명현감약,miR-34b적상대표체량균명현승고,분별위처리전적49.5배화18.8배.지질체전염hsa-miR-34b도K562세포기전염효솔위61%,CCK-8법검측hsa-miR-34b전염조각시기균출현세포증식억제작용,여음성대조전염조상비,차이유통계학의의(48 h:t=9.303,P<0.01;72 h:t=65.617,P<0.01;96 h:t =36.878,P <0.01;120 h:t=18.748,P<0.01).억제솔분별위12.2%、45.7%、32.5%、22.9%,기중72 h억제작용최명현.결론 계동자구CpG도갑기화사miR-34b재백혈병세포주표체강저,도치세포증식억제작용감약,가능시백혈병발생혹발전적원인지일.
Objective To study the expression level and CpG island methylation status of miR-34b in leukemia cell lines and to research the effect of DNA methylation on the proliferation of leukemia cells regulated by miR-34b.Method Taqman real-time fluorescence quantitative polymerase chain reaction (qRT-PCR) was carried out to detect the relative expression of miR-34b in control group (bone marrow cells of 20 children without blood disease) and 8 leukemia cell lines (U937,HL-60,MV4-11,M2R,K562,Raji,CCRF,DAMI).Methylation-specific polymerase chain reaction (MSP) was carried out to detect the methylation differences of miR-34b in control group (Bone marrow cells of 23 children without blood disease),8 leukemia cell lines.HL-60 and K562 were treated with methyltransferase inhibitor (5-aza-2-dC) for further detection of its methylation status and expression of miR-34b.Hsa-miR-34b mimics was transfected into K562 cell by liposome,the transfection efficiency was detected by flow cytometry.The cell proliferation of hsa-miR-34b transfected group in each stage was measured with CCK-8 assay,and then compared with non-transfected group and negative control group.Result The relative expression level of miR-34b in the group of children without blood disease and the group of leukemia cell lines were 5.22 ± 1.15,0.03 ±0.03.The results showed that,the group of leukemia cell lines was significantly different from the control group(t =4.538,P < 0.01).Eight leukemia cell lines showed methylation,the positive rate of the methyl was 100%.There was no methylation in the 23 cases of control group.After leukemia cell lines HL-60 and K562 were treated with 5-aza-2-dC,the methylated bands became obviously weakened,and the relative expression levels of miR-34b substantially increased 49.5 times and 18.8 times respectively.After hsa-miR-34b mimics was transfected into K562 cell by liposome,its transfection efficiency detected by flow cytometry was 61% and the cell proliferation was measured with CCK-8 assay from which it was found that the cell proliferation was significantly suppressed compared with the control group at 48 h (t =9.303,P < 0.01),72 h (t=65.617,P<0.01),96 h (t=36.878,P<0.01) and 120 h (t=18.748,P<0.01) in hsa-miR-34b transfected group,with the inhibition rate of 12.2% (48 h),45.7% (72 h),32.5% (96 h) and 22.9% (120 h).Conclusion The hypermethylation of promoter leads to decrease in the expression levels of miR-34b in leukemia cell lines,which attenuate mechanism of proliferative inhibition may be one of the reasons of occurrence or development of childhood leukemia.